RECOGNITION : CLINICAL TEST SHOW POSITIVE RESULT FOR DIABETES

Randomized, double-blind, placebo-controlled clinical test

Leader : Dr. Tai Tung-Yuan

* Former Principle of Taiwan National University College of Medicine

* Renown Taiwan Diabetes Specialist

* Director of Taiwan Diabetes Association

Clinical Trial Team :
1. Taiwan National University Hospital, participant Dr. Zhuang Li Meng
specialist in Molecular Virology
2.Tri-Service General Hospital, participant Dr. Kuo Xi Wen specialist
in Metabolism
3.Taichung Veterans General Hospital, participant Dr. Hsu Hui Heng
specialist in Metabolism
4. National Cheng-Kung University Hospital, participant Dr. Wu Da Ren
specialist in Metabolism
5. Jian Ya Biotechnology Cooperation, participant Dr. Chang Qi Tai
specialist in New Medicine Exploitation

Hospitals:

This clinical test was carried out in four renowned hospitals in
Taiwan:

* National Cheng-Kung University Hospital

* National Taiwan University Hospital

* Tri-Service General Hospital

* Taichung Veterans General Hospital

This clinical test has shown that GT&F(R) Milk Powder is effective in
lowering fasting plasma glucose in diabetes patients.

Clinical Test Results: (published in The 25 th Annual Meeting of The
Endocrinology Society and The Diabetes Association of The R.O.C. 2004)

RESEARCH FINDING
The followings are the status of various R&D work and product testing
conducted on GT&F Milk Powder:

1. Content Analysis Completed: Samples from 3 different batches of
milk powder produced were sent for ingredient and quality control
analysis. The analysis was conducted and report was issued by the Food
Industry Development Research Centre.

2. Product Stability Analysis Completed: The analysis was conducted by
the physiology lab in the Veterinary faculty of the Taiwan Chung-Hsing
University and GMP Chinese Medicine Factory. The analysis results show
that GT&F Milk Powder is stable in form and its drying and health
supplement ingredient are meeting product stability standard.

3. Product Effectiveness Testing Completed: This testing was conducted
by the physiology lab in the veterinary faculty of the Taiwan Chung-
Hsing University. The product effectiveness testing had been
completed.

4. Genetic Toxicity Testing Completed: This testing was conducted by
the Food Industry Development Research Centre. Outcome of these tests
proved that GT&F Milk Powder does not have genetic toxicity.

5. Oral Consumption Instant Toxicity Test Completed: This test was
conducted by Agricultural Committee Agriculture Chemicals Testing
Laboratory. Testing outcome showed that the sample had no toxic effect
on laboratory rats. After 7 - 14 days, the test group rats have
significant weight increase as compared to the rats from the control
group. Analysis on internal organs of the test rats had indicated no
harmful effect. The Oral Consumption Instant Toxicity Dosage (LD50)
had shown to be at 5,000mg per kilogram body weight. This test
confirmed that GT&F Milk Powder is not toxic.

6. 28-day Oral Toxicity Test Completed: This test was conducted by
Agricultural Committee Agriculture Chemicals Testing Laboratory. Based
on analysis on clinical symptoms, weight changes, food intake, eye
checks, blood tests, serum analysis, etc. on the laboratory rats, no
toxic reaction was indicated. The NOAEL dosage based on the 28-day
oral toxicity test was determined to be 1000mg/kg of body weight. This
test confirmed that GT&F Milk Powder is not toxic.

7. Human Clinical Trial Completed: This double-blind clinical trial
was conducted in four major teaching hospitals in Taiwan: the Taiwan
National University College of Medicine, Tai Chung Veterans General
Hospital, National Cheng-Kong University Hospital and Army General
Hospital. It was led by renown diabetes expert - Dr. Tai Dung-Yuan.
Dr. Tai is the chairman of Taiwan Diabetic Association and former
principal of the Taiwan National University College of Medicine. This
trial was completed in 2004 and its final results had been publicized
in July 2004. According to this trial, GT&F Milk Powder is effective
in reducing blood glucose level and improves the symptoms of diabetes.

Innovation Incubator:
The research division of Maxluck Biotechnology Ltd. was officially
located into the Innovation Incubator of National Chung-Hsing
University in June 2000. The elite research team is led by Dr. Mao Jia-
hung, PhD in endocrinology of Wisconsin University.

DETAILS : http://diabetes-diet-and-nutrition.blogspot.com/2008/04/recognition-clinical-tes
t-show-positive.html